CS logo
small CS logo
Ralph H. Johnson VA Medical Center, Charleston, SC

Charleston, South Carolina, United States
Hospital in Charleston, South Carolina
109 Bee St, Charleston, SC 29401

About Ralph H. Johnson VA Medical Center, Charleston, SC


"Serving Veterans along the South Carolina and Georgia Coast for more than 50 years."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Ralph H. Johnson VA Medical Center, Charleston, SC


During the past decade, Ralph H. Johnson VA Medical Center, Charleston, SC conducted 104 clinical trials. In the 10-year time frame, 104 clinical trials started and 56 clinical trials were completed, i.e. on average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 29 clinical trials were completed. i.e. 47.5% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Ralph H. Johnson VA Medical Center, Charleston, SC" #1 sponsor was "VA Office of Research and Development" with 67 trials, followed by "SWOG Cancer Research Network" with 39 trials sponsored, "US Department of Veterans Affairs" with 17 trials sponsored, "Medical University of South Carolina" with 10 trials sponsored and "Alliance for Clinical Trials in Oncology" with 10 trials sponsored. Other sponsors include 56 different institutions and companies that sponsored additional 46 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ralph H. Johnson VA Medical Center, Charleston, SC" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "Medical University of South Carolina" with 10 trials as a collaborator, "Ralph H. Johnson VA Medical Center" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 87 different institutions and companies that were collaborators in the rest 74 trials.

Clinical Trials Conditions at Ralph H. Johnson VA Medical Center, Charleston, SC


According to Clinical.Site data, the most researched conditions in "Ralph H. Johnson VA Medical Center, Charleston, SC" are "Prostate Cancer" (14 trials), "PTSD" (12 trials), "Stroke" (12 trials), "Posttraumatic Stress Disorder" (10 trials) and "Lung Cancer" (8 trials). Many other conditions were trialed in "Ralph H. Johnson VA Medical Center, Charleston, SC" in a lesser frequency.

Clinical Trials Intervention Types at Ralph H. Johnson VA Medical Center, Charleston, SC


Most popular intervention types in "Ralph H. Johnson VA Medical Center, Charleston, SC" are "Drug" (115 trials), "Behavioral" (44 trials), "Other" (31 trials), "Biological" (17 trials) and "Device" (15 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (30 trials), "radiation therapy" (9 trials), "cisplatin" (8 trials), "paclitaxel" (7 trials) and "docetaxel" (6 trials). Other intervention names were less common.

Clinical Trials Genders at Ralph H. Johnson VA Medical Center, Charleston, SC


The vast majority of trials in "Ralph H. Johnson VA Medical Center, Charleston, SC" are 166 trials for "All" genders, 22 trials for "Male" genders and 10 trials for "Female" genders.

Clinical Trials Status at Ralph H. Johnson VA Medical Center, Charleston, SC


Currently, there are 65 active trials in "Ralph H. Johnson VA Medical Center, Charleston, SC". 6 are not yet recruiting, 42 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 107 completed trials in Ralph H. Johnson VA Medical Center, Charleston, SC, undefined suspended trials, and 20 terminated clinical trials to date.
Out of the total trials that were conducted in Ralph H. Johnson VA Medical Center, Charleston, SC, 5 "Phase 1" clinical trials were conducted, 60 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 51 trials that are defined as “Not Applicable".